Africa & Middle East

Although Tanzania has not reported any confirmed Ebola cases, the government continues to enhance preparedness measures through its national contingency plans.

Through this collaboration, both organisations will work to improve patient care by supporting healthcare professionals with access to the latest medical knowledge and best practices.

The CardioMEMS HF System continuously monitors pressure within the pulmonary artery, providing healthcare professionals with critical information about a patient’s cardiovascular status.

The approval expands the use of the therapy to delay the onset of Stage 3 Type 1 diabetes in children as young as one year old.

Khansaheb Investment LLC will transfer its 55 per cent stake, while Clemenceau Medical Company S.A.E.M.L. will sell its 25 per cent holding.

The assistance forms part of a wider U.S.-Madagascar health partnership established under the bilateral Global Health Memorandum of Understanding (MOU) signed in December 2025.

The EBO-PEP platform trial, which has been under development since 2024, will evaluate several medicines as post-exposure prophylaxis for people who have had high-risk contact with filoviruses, the virus family that includes Bundibugyo Ebola.

The signing ceremony brought together National Treasury and Economic Planning Cabinet Secretary John Mbadi, U.S. Chargé d’Affaires Susan Burns, Health Cabinet Secretary Aden Duale, senior government officials and representatives from both countries.

The launch includes eight hospital-grade hemodialysis concentrate solutions designed to support the treatment of patients living with kidney failure.